This study investigated agreement between boys and their parents when reporting on health-related quality of life and the effects of steroid use, age, and physical functioning on self-reported health-related quality of life in boys with Duchenne muscular dystrophy. The Pediatric Quality of Life Inventory™ and brief functional measures were administered to 35 parent-son dyads. We found that agreement between parents and their sons was moderate (intraclass correlation coefficient [ICC]2,1 = 0.66; 95% confidence interval [CI], 0.40-0.80) to poor (ICC2,1 = 0.64; 95% CI, 0.43-0.64). The boys’ self-reports revealed a relationship between disease progression and physical functioning (r = —.75; P = .01); however, disease stage was not related to psychosocial functioning (r = —.27; NS). Parents and boys affected by Duchenne muscular dystrophy have a moderate to poor agreement on health-related quality of life measures, with parents reporting lower overall health-related quality of life when compared with their sons.
Emery A.Population frequencies of inherited neuromuscular diseases: a world survey . Neuromuscul Disord. 1991;1:19-29.
2.
Chamberlain JS, Rando TA, eds. Duchenne Muscular Dystrophy: Advances in Therapeutics . New York: Taylor & Francis Group; 2006.
3.
WhoqolgroupThe World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-1409.
4.
Liddle J., McKenna K.Quality of life: an overview of the issues for use in occupational therapy outcome measurement. Aust Occup Ther J. 2000 ;47:77-85.
5.
Barge-Schaapveld D., Nicolson N., Delespaul P., deVries MWAssessing daily quality of life with the experience sampling method . In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. West Sussex: John Wiley & Sons Ltd; 2006:91-101.
6.
Levi R., Drotar D.Critical issues and needs in health-related quality of life assessment of children and adolescents with chronic health conditions. In: Drotar D, ed. Measuring Health-related Quality of Life in Children and Adolescents: Implications for Research and Practice . Mahwah, NJ: Lawrence Erlbaum Associates Inc;1998:3-24.
7.
Varni JW, Seid M., Kurtin PSPedsQL™ 4.0: reliability and validity of the Pediatric Quality of Life Inventory™ version 4.0 generic scales in healthy and patient populations . Med Care. 2001;39(8): 800-812.
8.
Davis E., Waters E., Mackinnon A., et al. Paediatric quality of life instruments: a review of the impact of the conceptual framework on outcomes. Dev Med Child Neurol . 2006;48:311-318.
9.
De Civita M. , Regier D., Alamgir AH, et al. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics . 2005;23:659-685.
10.
Solans M., Pane S., Estrada M., et al. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health. 2008;11: 742-764.
11.
Matza LS, Swensen AR, Flood EM, Secnik K., Leidy NKAssessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health. 2004;7:79-92.
12.
Dickinson HO , Parkinson KN, Ravens-Sieberer U., et al. Self-reported quality of life of 8-12-year-old children with cerebral palsy: a cross-sectionalEuropean study. Lancet. 2007;369: 2171-2178.
13.
Eiser C., Morse R.Can parents rate their child’s health-related quality of life? Results of a systematic review. Qual Life Res. 2001 ;10:347-357.
14.
Connolly MA , Johnson JAMeasuring quality of life in paediatric patients . Pharmacoeconomics. 1999;16:605-625.
15.
Havermans T. , Vreys M., De Boeck C.Assessment of agreement between parents and children on health related quality of life in children with cystic fibrosis . Child Care Health Dev. 2006; 32:1-7.
16.
Youssef NN, Murphy TG, Langseder AL, Rosh JRQuality of life for children with functional abdominal pain: a comparison study of patients’ and parents’ perceptions. Pediatrics. 2006;117:54-59.
17.
Klassen AF, Miller A., Fine S.Agreement between parent and child report of quality of life in children with attention-deficit/ hyperactivity disorder. Child Care Health Dev. 2006;32:397-406.
18.
Cotton S., Voudouris NJ, Geenwood KMAssociation between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis . Dev Med Child Neurol. 2005;47:257-265.
19.
Rikard KW, Margareta K., Lennart M., Orvar E.Specific cognitive deficits are common in children with Duchenne muscular dystrophy. Dev Med Child Neurol. 2004;46:154.
20.
Mah JK, Thannhauser JE, Kolski H., Dewey D.Parental stress and quality of life in children with neuromuscular disease . Pediatr Neurol. 2008;39:102-107.
21.
Steffensen BF , Lyager S., Werge B., Rahbek J., Mattsson E.Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002;44:623-632.
22.
Erby LH, Rushtin C., Geller G.My son is still walking: stages of receptivity to discussions of advance care planning among patients of sons with Duchenne muscular dystrophy. Semin Pediatr Neurol. 2006;13:132-140.
23.
McDonald Cmmd, Carter GT, Han JJ, Benditt JORehabilitation management of Duchenne muscular dystrophy. In: Chamberlain JS, Rando TA, eds. Duchenne Muscular Dystrophy: Advances in Therapeutics . New York: Taylor & Francis Group; 2006: 149-175.
24.
Houde S., Filiatrault M., Fournier A., et al. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up . Pediatr Neurol. 2008;38:200-206.
25.
Kohler M., Clarenbach CF, Boni L., Brack T., Russi EW, Bloch KEQuality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2005; 172:1032-1036.
26.
Grootenhuis MA, de Boone J., van der Kooi A.Living with muscular dystrophy: health related quality of life consequences for children and adults. Health Qual Life Outcomes.2007 ;5:31. Available at: http://www.hqlo.com/content/5/1/31 . Accessed July 1, 2009.
27.
Darras BT, Menache CC, Kunkel LMDystrophinopathies. In: Jones HR, De Vivo DC, Darras BT, eds. Neuromuscular Disorders of Infancy, Childhood and Adolescence: A Clinician’s Approach. Philadelphia : Butterworth-Heinemann;2003:649-700.
28.
Woodcock RW , McGrew KS, Meather N.Woodcock-Johnson III Tests of Achievement . Itasca, IL: Riverside Publishing ; 2001.
29.
Varni J., Seid M.The PedsQL: measurement model for pediatric quality of life inventory . Med Care. 1999;37:126-139.
30.
Varni JW, Burwinkle TM, Seid M., Skarr D.The PedsQL™ 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329-341.
31.
Varni JW, Seid M., Knight TS, et al. The PedsQL™ 4.0 generic core scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med. 2002;25:175-193.
32.
Varni JW, Limbers CA, Burwinkle TMImpaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 generic core scales. Health Qual Life Outcome.2007;5:43. Available at: http://www.hqlo.com/content/5/1/43 . Accessed July 1, 2009.
33.
Eiser C.Children’s quality of life measures. Arch Dis Child . 1997; 77:350-354.
34.
Vignos PJ, Spencer GE, Archibald KCManagement of progressive muscular dystrophy in childhood. JAMA. 1963;184:89-96.
35.
Vignos PJ, Wagner MB, Karlinchak B., Katirji B.Evaluation of a program for long-term treatment of Duchenne muscular dystrophy: experience at the University Hospitals of Cleveland. J Bone Joint Surg. 1996;78:1844-1852.
36.
Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJClinical trial in Duchenne dystrophy. I: the design of the protocol . Muscle Nerve. 1981;4:186-197.
37.
Upton P., Lawford J., Eiser C.Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res. 2008;17:895-913.
38.
Fleiss JLReliability of Measurement: The Design and Analysis of Clinical Experiments . New York: John Wiley & Sons ; 1986.
39.
Bushby K., Muntoni F., Urtizberea A., et al. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy: defining the gold standards of management in the use of corticosteroids. Neuromuscul Disord. 2004;14: 526-534.
40.
Hilton T., Orr RD, Perkin RM, Ashwal S.End of life care in Duchenne muscular dystrophy. Pediatr Neurol . 1993;9:165-177.
41.
Bothwell JE , Dooley JM, Gordon KE, MacAuley A., Camfield PR, MacSween J.Duchenne muscular dystrophy: parental perceptions . Clin Pediatr. 2002;41:105-109.
42.
World Health Organization.International Classification of Functioning, Disability and Health: ICF. Geneva: World Health Organization; 2001.
43.
Rosenbaum P.Children’s quality of life: separating the person from the disorder. Arch Dis Child. 2008;93:100-101.
44.
Bolger N., Davis A., Rafaeli E.Diary methods: capturing life as it is lived. Annu Rev Psychol . 2003;54:579-616.
45.
Bray P., Bundy AB, Ryan MM, North KNFeasibility of a computerized method to measure quality of ‘everyday’ life in children with neuromuscular disorders. Phys Occup Ther Pediatr. In press.
46.
Buffart LM, Van Den Berg-Emons RJG, Van Meeteren J., Stam HJ, Roebroeck MELifestyle, participation, and health-related quality of life in adolescents and young adults with myelomeningocele. Dev Med Child Neurol . 2009;51:886-894.
47.
Bach J., Vega J., Majors J., Friedman A.Spinal muscular atrophy type 1 quality of life. Am J Phys Med Rehabil. 2003;82:137-142.
